The information provided on this site is for informational purposes only and is not intended as a substitute for advice from your physician or other health care professional or any information contained on or in any product label or packaging
Learn more Restricted Access Qualified Professionals Only This site sells reference compounds for laboratory research
This systematic review, conducted by researchers from the Beijing University of Chinese Medicine and the University of Chicago, analyzed data from 76 studies to assess the safety and efficacy of fifteen glucagon-like peptide-1 (GLP-1) receptor agonists used in the treatment of type 2 diabetes
Case in point: In South Carolina, where more than one-third of all adults, and nearly half of the African American population, qualify as obese, the state Medicaid agency estimates only 1,300 beneficiaries will meet the stringent prerequisites for GLP-1 coverage
SUSTAIN-6 was pivotal, revealing a 26% reduction in adverse heart outcomes
